Nanopharm - Crunchbase Company Profile & Funding

Start Free Trial

Overview

Nanopharm

Growth Score

80

Heat Score

44

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Nanopharm

CB Rank

729283

Nanopharm is a provider of orally inhaled and nasal drug product design and development services.

Acquired by

Founded

obfuscation

Private

Newport, Newport, United Kingdom

nanopharm.co.uk/

Details

Operating Status

Active

Company Type

For Profit

About the Company

Nanopharm is a provider of orally inhaled and nasal drug product design and development services. Nanopharm is a science-driven, leading provider of orally inhaled and nasal drug product design and development services.

Phone Number

+44 (0) 1633 504 776

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

OINDP Development Services

Services for developing orally inhaled and nasal drug products across all stages from preclinical to commercialization.

SmartTrack™ Platform

A proprietary in vitro and in silico modeling system to demonstrate bioequivalence of inhaled generic drug products without clinical endpoint studies.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

M&A Details

was acquired by

on

obfuscation

.

Transaction Name

Nanopharm acquired by Aptar Pharma

Acquired by

Announced Date

obfuscation

Market Intelligence

People

View Profiles & Contacts

Headcount

Contacts

News

News and Press

News•

Mar 16, 2026

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

News•

Apr 16, 2025

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

Access a complete feed of recent news and press, from product launches to leadership changes.

Technology

View Tech Report

Monthly Web Visits

334

-28.33%

in past month

IT Spend

$190.2K

This year,

is projected to spend

on IT, according to Aberdeen.

Active Website Tech Count

40

is actively using

40

technologies for its website, according to BuiltWith. These include

,

IPhone / Mobile Compatible

, and

.

Total IP

14

The intellectual property of

includes

registered patents primarily in the '

' category, according to IPqwery. Additionally,

has

registered trademark in the '

Pharmaceutical, veterinary and sanitary products

' class, according to IPqwery.

Lists Featuring This Company

Lists Featuring This Company

Companies That Exited in 2019 (Top 10K)

9,696 Number of Organizations • $404.7B Total Funding Amount • 12,434 Number of Investors

Medical Acquired Companies With Fewer Than 10 Employees

501 Number of Organizations • $2.7B Total Funding Amount • 501 Number of Investors

Europe, Middle East, and Africa (EMEA) Acquired Companies With Fewer Than 10 Employees

4,719 Number of Organizations • $13.2B Total Funding Amount • 2,429 Number of Investors

Europe, Middle East, and Africa (EMEA) Pharmaceutical Acquired Companies

822 Number of Organizations • $20B Total Funding Amount • 599 Number of Investors

Sub-Organizations

Frequently Asked Questions

Where is

's headquarters?

is located in

Newport, Newport, United Kingdom

.

Who are

's competitors? Alternatives and possible competitors to

may include

,

, and

.